Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Director departure
Quarterly results
Appointed COO
Appointed director

HUMANIGEN, INC (HGEN) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
08/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/25/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
04/19/2023 8-K Quarterly results
04/06/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and...
03/13/2023 8-K Regulation FD Disclosure  Interactive Data
03/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
02/24/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
02/01/2023 SC 13G/A Murchinson Ltd. reports a 0% stake in Humanigen, Inc.
12/22/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
11/14/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/14/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
09/29/2022 8-K Quarterly results
09/02/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/26/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/12/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/12/2022 8-K Quarterly results
08/09/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
07/29/2022 4 Buxton Cheryl (Director) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 78,362 options to buy @ $0.38, valued at $29.8k
07/29/2022 4 Hohneker John (Director) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 63,195 options to buy @ $0.38, valued at $24k
07/29/2022 4 BARLIANT RONALD (Director) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 55,612 options to buy @ $0.38, valued at $21.1k
07/29/2022 4 Kilcoyne Adrian (Chief Medical Officer) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 537,164 options to buy @ $0.38, valued at $204.1k
07/29/2022 4 Chappell Dale (Chief Scientific Officer) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 518,205 options to buy @ $0.38, valued at $196.9k
07/29/2022 4 Boehm Rainer J. (Director) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 73,307 options to buy @ $0.38, valued at $27.9k
07/29/2022 4 Jordan Edward P. (Chief Commercial Officer) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 455,010 options to buy @ $0.38, valued at $172.9k
07/29/2022 4 MORRIS TIMOTHY E (COO and CFO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 600,360 options to buy @ $0.38, valued at $228.1k
07/29/2022 4 Xie Yili Kevin (Director) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 83,418 options to buy @ $0.38, valued at $31.7k
07/29/2022 4 Durrant Cameron (CEO) has filed a Form 4 on HUMANIGEN, INC
Txns: Granted 808,906 options to buy @ $0.38, valued at $307.4k
07/26/2022 8-K Quarterly results
07/13/2022 8-K Quarterly results
06/30/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy